George et al., Monoclonal Antibodies Raised Against the Idiotype of the Murine B Cell Lymphoma, BCL.sub.1 Act Primarily with Heavy Chain Determinants, Hybridoma 10:219-227 (1991). |
Hata et al., Tyrosine Phosphorylaiton of IqM-and IqD-Associated Molecules of a Human B Lymphoma Cell Line B104, International Immunology 4:797-804 (1992). |
Lam K.S., Treatment of a B-Cell Lymphoma Using Peptides a Novel Concept, the Western Journal of Medicine 158:475-479 (1993). |
Renschler and Levy, Overcoming the Limitations of Chemotherapy in the Treatment of B-Cell Non-Hodgkin's Lymphomas--An Approach Using Radiolabeled Peptide Ligands, the Western Journal of Medicine 158:530-532 (1993). |
Smith et al., Production of Heterologous Antibodies Specific for Murine B-Cell Leukemia Immunoglobulin by Immunization with Synthetic Peptides Homologous to Heavy Chain Hypervariable Regions, Cancer Research 45:6119-6123 (1985). |
Thielemans et al., Syngeneic Antidiotypic Immune Respones to A B Cell Lymphoma, J. Exp. Med. 162:19-34 (1985). |
Levy et al., Therapy of Lymphana Directed at Idio Types, J. Natl Cancer Inst Monographs 10: 61-68, 1990. |